Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients

Autoimmunity

Volumn 46, Issue 4, 2013, Pages 279-284

  Muro, Yoshinao ^a   Sugiura, Kazumitsu ^a   Akiyama, Masashi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti SAE antibody; Dermatomyositis; ELISA; Immunoprecipitation Western blotting; Small ubiquitin like modifier activating enzyme

Indexed keywords

SUMO 1 PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYOSITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; JAPANESE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PULMONARY HYPERTENSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INFANT; MALE; MIDDLE AGED; UBIQUITIN-ACTIVATING ENZYMES; YOUNG ADULT;

EID: 84877741907     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2012.755958     Document Type: Article

References (27)

1. Mammen, A. L. 2010. Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis. Ann. NY Acad. Sci. 1184: 134-153
2. Sarkar, K., and F. W. Miller. 2004. Autoantibodies as predictive and diagnostic markers of idiopathic inflammatory myopathies. Autoimmunity 37: 291-294
3. Ghirardello, A., S. Zampieri, E. Tarricone, et al. 2006. Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity 39: 217-221
4. La Corte, R., A. LoMonaco, A. Locaputo, F. Dolzani, and F. Trotta. 2006. In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease. Autoimmunity 39: 249-253
5. Ghirardello, A., S. Zampieri, L. Iaccarino, et al. 2005. Anti- Mi-2 antibodies. Autoimmunity 38: 79-83
6. Zampieri, S., A. Ghirardello, L. Iaccarino, et al. 2005. Anti- Jo-1 Antibodies. Autoimmunity 38: 73-78
7. Mielnik, P., E. Wiesik-Szewczyk, M. Olesinska, H. Chwalinska- Sadowska, and J. Zabek. 2006. Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies. Autoimmunity 39: 243-247
8. Yoshifuji, H., T. Fuji, S. Kobayash, et al. 2006. Antiaminoacyl- tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 39: 233-241
9. Hoshino, K.,Y. Muro,K. Sugiura, et al. 2010. Anti-MDA5 and anti-TIF1-g antibodies have clinical significance for patients with dermatomyositis. Rheumatology 49: 1726-1733
10. Betteridge, Z., H. Gunawardena, J. North, and N. McHugh. 2007. Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis. Arthritis Rheum. 56: 3132-3137
11. Betteridge, Z. E., H. Gunawardena, H. Chinoy, et al. 2009. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target in UK Caucasian adult-onset myositis. Ann. Rheum. Dis. 68: 1621-1625
12. Ghirardello, A., S. Zampieri, E. Tarricone, et al. 2011. Cutting edge issues in polymyositis. Clinic Rev. Allerg. Immunol. 41: 179-189
13. Muro, Y., A. Ishikawa, K. Sugiura, and M. Akiyama. 2012. Clinical features of anti-TIF1-a antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-g or anti-Mi-2 autoantibodies. Rheumatology 51: 1508-1513
14. Bohan, A., and J. B. Peter. 1975. Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med. 292: 344-347
15. Bohan, A., and J. B. Peter. 1975. Polymyositis and dermatomyositis (second of two parts). N. Engl. J. Med. 292: 403-407
16. Sontheimer, R. D. 2002. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J. Am. Acad. Dermatol. 46: 626-636
17. Bohan, A., J. B. Peter, R. L. Bowman, and C. M. Pearson. 1977. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 56: 255-286
18. Chinoy, H., N. Fertig, C. V. Oddis, W. E. Ollier, and R. G. Cooper. 2007. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann. Rheum. Dis. 66: 1345-1349
19. Ishikawa, A., Y. Muro, K. Sugiura, and M. Akiyama. 2012. Development of an ELISA for detection of autoantibodies to nuclear matrix protein 2. Rheumatology (Oxford) 51: 1181-1187
20. Watanabe, A., M. Kodera, K. Sugiura, et al. 2004. Anti- DFS70 antibodies in 597 healthy workers. Arthritis Rheum. 50: 892-900
21. Watanabe, K., Y. Muro, K. Sugiura, and Y. Tomita. 2011. IgE and IgG4 autoantibodies against DFS70/LEDGF in atopic dermatitis. Autoimmunity 44: 511-519
22. Muro, Y., K. Sugiura, K. Hoshino, and M. Akiyama. 2012. Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DM/interstitial lung disease during disease remission. Rheumatology (Oxford) 51: 800-804
23. Minai, O. A. 2009. Pulmonary hypertension in polymyositisdermatomyositis: Clinical and hemodynamic characteristics and response to vasoactive therapy. Lupus 18: 1006-1010
24. Betteridge, Z. E., H. Gunawardena, and N. J. McHugh. 2011. Novel autoantibodies and clinical phenotypes in adult and juvenile myositis. Arthritis Res. Ther. 13: R209
25. Rosendorff, A., S. Sakakibara, S. Lu, et al. 2006. NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression. Proc. Natl. Acad. Sci. USA 103: 5308-5313
26. Stielow, B., A. Sapetschnig, I. Krüger, et al. 2008. Identification of SUMO-dependent chromatin-associated transcriptional repression components by a genome-wide RNAi screen. Mol. Cell 29: 742-754
27. Agricola, E., R. A. Randall, T. Gaarenstroom, S. Dupont, and C. S. Hill. 2011. Recruitment of TIF1g to chromatin via its PHD finger-bromodomain activates its ubiquitin ligase and transcriptional repressor activities. Mol. Cell 43: 85-96. Caucasian adult-onset myositis. Ann. Rheum. Dis. 68: 1621-1625